These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 8524605)
21. PCNA independence of Ki-67 expression in HPV infection. Boon ME; Howard CV; van Velzen D Cell Biol Int; 1993 Nov; 17(11):1001-4. PubMed ID: 7906585 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms. Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113 [TBL] [Abstract][Full Text] [Related]
23. Prognostic value of ploidy and proliferation markers in renal cell carcinoma. Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925 [TBL] [Abstract][Full Text] [Related]
24. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labeling indices. Oka K; Nakano T; Hoshi T Cancer; 1996 Jun; 77(11):2280-5. PubMed ID: 8635096 [TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical study of seminiferous epithelium in adult bovine testis using monoclonal antibodies against Ki-67 protein and proliferating cell nuclear antigen (PCNA). Wrobel KH; Bickel D; Kujat R Cell Tissue Res; 1996 Feb; 283(2):191-201. PubMed ID: 8593648 [TBL] [Abstract][Full Text] [Related]
26. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma. Lam KY; Law SY; So MK; Fok M; Ma LT; Wong J Cancer; 1996 Jan; 77(1):7-13. PubMed ID: 8630942 [TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors. Albers P; Orazi A; Ulbright TM; Miller GA; Haidar JH; Donohue JP; Foster RS Mod Pathol; 1995 Jun; 8(5):492-7. PubMed ID: 7545814 [TBL] [Abstract][Full Text] [Related]
30. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [TBL] [Abstract][Full Text] [Related]
31. MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activity. Garzetti GG; Ciavattini A; Lucarini G; Goteri G; de Nictolis M; Muzzioli M; Fabris N; Romanini C; Biagini G Gynecol Oncol; 1995 Jul; 58(1):28-33. PubMed ID: 7789886 [TBL] [Abstract][Full Text] [Related]
32. Image cytometric comparison of proliferating cell nuclear antigen and MIB-1 staining in hepatocellular carcinoma and adjacent liver tissue. Wells SJ; DeRose PB; Cohen C Cytometry; 1996 Sep; 26(3):198-203. PubMed ID: 8889391 [TBL] [Abstract][Full Text] [Related]
33. Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin-fixed paraffin sections. Skalova A; Leivo I; Von Boguslawsky K; Saksela E J Pathol; 1994 May; 173(1):13-21. PubMed ID: 7931834 [TBL] [Abstract][Full Text] [Related]
34. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma]. Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706 [TBL] [Abstract][Full Text] [Related]
35. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings. Serio G Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759 [TBL] [Abstract][Full Text] [Related]
36. Nerve fibres in urothelium and submucosa of neuropathic urinary bladder: an immunohistochemical study with S-100 and neurofilament. Vaidyanathan S; van Velzen D; Krishnan KR; Parsons KF; Soni BM; Woolfenden A; Fraser MH; Howard CV Paraplegia; 1996 Mar; 34(3):137-51. PubMed ID: 8668354 [TBL] [Abstract][Full Text] [Related]
37. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors. Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650 [TBL] [Abstract][Full Text] [Related]
38. Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR. Biesterfeld S; Klüppel D; Koch R; Schneider S; Steinhagen G; Mihalcea AM; Schröder W J Pathol; 1998 May; 185(1):25-31. PubMed ID: 9713356 [TBL] [Abstract][Full Text] [Related]
39. PCNA Ki-67 dissociation in childhood acute lymphoblastic leukaemia. An immunofluorescent laser confocal scanning microscopical study. Ball LM; Pope J; Howard CV; Eccles P; van Velzen D Cell Biol Int; 1994 Sep; 18(9):869-74. PubMed ID: 8000360 [TBL] [Abstract][Full Text] [Related]
40. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas. Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]